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In Brief
Smyllie et al. use a fluorescent reporter
mouse to image the circadian dynamics
of PER2, a key component of the
circadian clock in the suprachiasmatic
nucleus and fibroblasts. They reveal
marked divergence of the mechanisms of
mouse and fly clock cells, and they
provide quantitative data to support
reappraisal of current models of the
mammalian clock.
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Transcriptional-translational feedback loops (TTFLs)
are a conserved molecular motif of circadian clocks.
The principal clock in mammals is the suprachias-
matic nucleus (SCN) of the hypothalamus. In SCN
neurons, auto-regulatory feedback on core clock
genes Period (Per) andCryptochrome (Cry) following
nuclear entry of their protein products is the basis of
circadian oscillation [1, 2]. In Drosophila clock neu-
rons, the movement of dPer into the nucleus is sub-
ject to a circadian gate that generates a delay in the
TTFL, and this delay is thought to be critical for oscil-
lation [3, 4]. Analysis of the Drosophila clock has
strongly influenced models of the mammalian clock,
and such models typically infer complex spatiotem-
poral, intracellular behaviors of mammalian clock
proteins. There are, however, no direct measures of
the intracellular behavior of endogenous circadian
proteins to support this: dynamic analyses have
been limited and often have no circadian dimension
[5–7]. We therefore generated a knockin mouse ex-
pressing a fluorescent fusion of native PER2 protein
(PER2::VENUS) for live imaging. PER2::VENUS reca-
pitulates the circadian functions of wild-type PER2
and, importantly, the behavior of PER2::VENUS runs
counter to the Drosophila model: it does not exhibit
circadian gating of nuclear entry. Using fluorescent
imaging of PER2::VENUS, we acquired the first
measures of mobility, molecular concentration, and
localization of an endogenous circadian protein in in-
dividual mammalian cells, and we showed how the
mobility and nuclear translocation of PER2 are regu-
lated by casein kinase. These results provide new
qualitative and quantitative insights into the cellular
mechanism of the mammalian circadian clock.1880 Current Biology 26, 1880–1886, July 25, 2016 ª 2016 The Auth
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Generation and Validation of PERIOD2::VENUS Mouse
We used homologous recombination to knock in a fluorescent
tag at the Per2 locus, an equivalent strategy to that used for
the PER2::LUC mouse, which is known to exhibit wild-type
(WT) PER2 behavior [8]. Venus was fused to exons 19–23 of
mPer2 (Figure S1A). The presence of PER2::VENUS protein
expression was confirmed by fluorescence microscopy in
the brain and in lung fibroblasts (Figures 1A and 1B). As
well as strong fluorescence in the suprachiasmatic nucleus
(SCN), limited expression was observed in the piriform cortex,
thalamus, and hippocampus (Figure S1B). Importantly, the
spatial distribution of PER2::VENUS co-localized completely
with PER2 immunoreactivity (-ir) in Per2WT/Venus SCN (Figures
S1C–S1E).
To test for normal circadian function in Per2Venus/Venus animals,
we first assessed wheel-running behavior. They entrained effec-
tively to a 12-hr light/12-hr dark schedule (12:12 LD), and they
exhibited consolidated circadian activity patterns of wheel-
running when placed in constant conditions (Figures 1C, S1F,
and S1G). There were no significant differences between WT
and Per2Venus mice in the distribution, structure, or robustness
(measured by non-parametric circadian rhythm analysis) of
circadian behavior. After crossing with Per1-luc reporter mice,
Per2Venus/Venus SCN organotypic slices expressed robust, high-
amplitude circadian bioluminescence rhythms (Figures 1D and
S1H). The circadian periods of behavioral and SCN rhythms
were not significantly different between WT and Per2Venus/Venus
mice (Figures 1E and 1F). Thus, PER2::VENUS did not compro-
mise molecular pacemaking in the SCN or effective circadian
control over behavior. To confirm that Per2Venus did not encode
a loss-of-function mutation, Per2Venus mice were crossed to
Per1/ mice. In the absence of PER1, WT PER2 is a necessary
and sufficient component of the circadian pacemaker [9].
Per2Venus/Venus, Per1/ mice exhibited robust and sustained
wheel-running and SCN bioluminescence rhythms (Figures S1I
and S1J), with comparable periods to Per2WT/WT, Per1/ mice
(Figure S1K). Thus, Per2Venus encodes a functional allele ofors. Published by Elsevier Ltd.
commons.org/licenses/by/4.0/).
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Figure 1. PER2::VENUS Fusion Protein Is a Competent Circadian Clock Protein Suitable for Real-Time Imaging
(A) PER2::VENUS fluorescence across the mouse brain, at the peak time of SCN expression (ZT12). Inset shows a close up of the SCN. Scale bar, 1 mm.
(B) Bright-field and fluorescence confocal images show Per2Venus lung fibroblasts. Scale bar, 20 mm.
(C) Representative, double-plotted wheel-running actograms for Per2WT (left) and Per2Venus (right) animals. Mice were entrained on a 12:12 LD cycle, followed by
a schedule of constant conditions (dim red light, represented by shaded gray).
(D) Representative, de-trended Per1-luc bioluminescence rhythms of SCN slices from Per2WT (left) and Per2Venus (right) mice are shown.
(E) Mean ± SEM circadian periods for wheel-running are shown (nWT = 6; nWT/V = 8; nV/V = 7).
(F) Mean ± SEM circadian periods for SCN slices (nWT = 6; nWT/V = 7; nV/V = 9). One-way ANOVA revealed no significant effect for either measure.
(G) Snapshots from confocal real-time imaging show PER2::VENUS fluorescence in representative Per2Venus (top panel), Per1 null (middle panel), and CK1εTau
(lower panel) in SCN slices.
(H) Snapshots from confocal real-time imaging show PER2::VENUS in fibroblasts. Scale bar, 20 mm.
(I) Mean fluorescence measures from recordings in (G) are shown.
(J) Mean fluorescence measures from recordings in (H) are shown.
See also Figure S1, Table S1, and Movie S1.PER2. Per2Venus mice were then crossed with CK1εTau mutants
to test whether PER2::VENUS can interact with CK1ε, a key
modulator of PER2 stability and circadian period [10]. In WT an-
imals, the CK1εTau/Tau mutation shortened period from 24 to20 hr (Figures S1I, S1J, and S1L) [10]. Per2Venus/Venus mice
showed comparable acceleration of SCN and behavioral
rhythms. Thus, Per2Venus encodes an endogenous fusion protein
that functions competently within the mammalian clock.Current Biology 26, 1880–1886, July 25, 2016 1881
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Figure 2. Circadian Subcellular Localization of PER2::VENUS
(A) Representative confocal images of SCN neurons from brain sections taken from Per2Venus animals across the LD cycle. PER2::VENUS -positive (green)
localization was compared with cytoplasmic immunostaining for AVP (red) and nuclear staining of DAPI (blue). Scale bar, 20 mm.
(B) Co-localization of PER2::VENUS and DAPI assessed by Mander’s coefficient analysis (M1, blue, co-localization of PER2::VENUS with DAPI; M2, yellow, co-
localization of DAPI with PER2::VENUS). Note that M2 changes across the day because the overall level of PER2::VENUS changes; thus, the proportion of DAPI
nuclei containing PER2::VENUS changes.
(C) Per2Venus SCN slices were fixed, counterstained with DAPI (blue), and imaged at different time points during the rising phase (CT0–CT9) of the PER2 circadian
cycle. Each image shows representative neurons found at that time point, rather than a representative field of view at that time point.
See also Figure S2.Intracellular Circadian Dynamics of Endogenous
PERIOD2
We next analyzed the rhythmicity of the PER2::VENUS protein.
A clear circadian oscillation of PER2::VENUS abundance was
detected by western blot in temperature-entrained lung fibro-
blasts (Figures S1M and S1N). PER2::VENUS was also highly
and rhythmically expressed in the SCN (Figures S1O and S1P).
At the peak of PER2 expression (zeitgeber time 12 [ZT12]), in
the SCN, PER2::VENUS was detected in effectively all arginine
vasopressin (AVP)-immunoreactive (ir) and vasoactive intestinal
peptide (VIP)-ir neurons but in <10% of gastrin-releasing peptide
(GRP)-ir neurons (Figure S2; Table S1). At the trough of the cycle
(CT0), only a few AVP-ir cells expressed PER2::VENUS (Table
S1). We next tested the utility of PER2::VENUS as a real-time
circadian reporter, using confocal microscopy. Both SCN slices
and lung fibroblasts exhibited stable, high-amplitude circadian
oscillations of fluorescence throughout 70 hr of recording (Fig-
ures 1G and 1H; Movie S1). In the SCN, PER2::VENUS peaked
appropriately at 1 and 4 hr, respectively, after Cry1-luc and
Per1-luc (Figures S3A and S3B). Circadian expression of PER2::
VENUS was well defined in the SCN with a Per1/ background
and accurately reported period shortening by the CK1εTaumuta-
tion. Thus, PER2::VENUS is a high-fidelity real-time reporter of
the behavior of an endogenous clock protein in SCN neurons
and fibroblasts.
We next determined the macrodynamics of PER2::VENUS.
Using cycloheximide to inhibit translation in SCN slices, we re-1882 Current Biology 26, 1880–1886, July 25, 2016vealed that PER2::VENUS has a half-life of2 hr, comparable
to that of PER2::LUC (Figures S3C–S3E) [10]. Consistent with
proteasomal degradation of Per2WT [11], application of the pro-
teasomal inhibitor MG132 at CT12 increased PER2::VENUS
levels above thoseof vehicle-treated lung fibroblasts (FigureS3F)
and SCN slices (Figures S3G and S3H). The nuclear export inhib-
itor leptomycin B, applied at CT12, significantly increased the
half-life of PER2::VENUS, suggesting that nuclear export facili-
tates degradation (i.e., PER2 is subject to degradation in the
cytoplasm; Figures S3I and S3J). Moreover, synchronization be-
tween cells in SCN slices was reduced following nuclear export
blockade, suggesting that timely nuclear export and degradation
are necessary for transcriptional-translational feedback loop
(TTFL) timing.
Gated nuclear entry of Per protein is considered a pivotal
feature of circadian timekeeping. We examined the subcellular
localization of PER2::VENUS in the SCN at different points
across the LD cycle. Although the overall abundance of
PER2::VENUS changed across the cycle, its subcellular localiza-
tion did not (Figure 2A). Mander’s M1 coefficient indicated
almost complete co-localization of Venus with nuclear DAPI
signal at all phases (Figure 2B): at no point was PER2::VENUS
excluded from the nucleus, with exclusively cytoplasmic
localization. To discount the possibility of a transient gate for
cytoplasmic retention and nuclear entry, cellular localization
was monitored in living SCN slices imaged during the rising
phase (CT0–CT9) of PER2 expression. Again, when detected,
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Figure 3. FCS of PER2::VENUS Protein in
Fibroblasts
(A) Schematic diagram illustrating the FCS proce-
dure. PER2::VENUS fluorescence was monitored
within a small confocal volume. Individual fluores-
cent molecules passed through the volume at a
given rate. The fluorescence signal of all of the
molecules in the volume was followed through
time. The concentration and rate of movement of
molecules were calculated by auto-correlating the
fluorescence signal.
(B) Fluorescence images and FCS-calibrated
quantification of PER2::VENUS concentration in
skin fibroblasts are shown.
(C) Circadian variation of nuclear concentration of
PER2::VENUS over time for eight representative
cells. Images were collected every 6 min but every
tenth image was analyzed; thus, there is a data
point every 1.12 hr.
(D) PER2::VENUS concentration in the nucleus at
CT12 (4–6 hr after temperature synchronization) is
shown (mean ± SEM).
(E) FCS data fit to a two-component diffusion
model, color coded by component (fast, light blue;
slow, dark blue), are shown.
See also Figures S3 and S4.PER2::VENUS was observed in the nucleus at all time points
(Figure 2C). This was also the case in fibroblasts, where (weak)
cytoplasmic fluorescence oscillated in phase with strong
nuclear fluorescence (Figures S3K–S3M). Thus, in marked
contrast to the temporal gating that delays Drosophila Per entry
to the nucleus to late subjective day (4, 5), the mouse ortholog,
PER2, is not subject to compartmental circadian gating in
SCN neurons or fibroblasts and nuclear accumulation occurs
progressively.
Quantitative Analysis of PERIOD2 Intracellular Mobility
and Abundance
Fluorescence correlation spectroscopy (FCS) was used to mea-
sure mobility and molecular abundance of PER2::VENUS in skin
fibroblasts (Figure 3A). Circadian changes in PER2::VENUS con-
centration were observed in fibroblast nuclei (Figure 3B); but,
importantly, calibration of fluorescence intensity to FCS-calcu-
lated concentration per nuclear volume enabled absolute quan-
tification of the molecular abundance of PER2::VENUS across
the circadian cycle (Figures 3C and S4A–S4D). This revealed a
10-fold amplitude cycle, with peak expression of 15,000
molecules per nucleus (>90% of cellular total; Figure 3D). Inter-
estingly, when FCS-derived auto-correlations were fit to a two-
component diffusion model, a bimodal distribution of diffusion
coefficients was determined for nuclear PER2. This indicates
that it exists in at least two molecular/dynamic states, possibly
as bound and unbound fractions (Figure 3E). The more mobile
fraction had a diffusion coefficient of 8 mm2s1. Furthermore,
at CT12 the number of nuclear PER2::VENUS molecules, their
diffusion rates, and the proportion displaying the slowly diffusing
component were not significantly different in CK1εTau fibroblasts
compared to WT (Figures S3E–S3G). This suggests that PER2
mobility within the nucleus is not affected in the mutant. Thus,we have presented the first quantitative measures of intracellular
dynamics of a mammalian circadian clock protein.
Fluorescence recovery after photobleaching (FRAP) was used
to further examine the intracellular behavior of PER2::VENUS.
Data obtained by photobleaching of fibroblast nuclei agreed
with the FCS-based calculations that intranuclear PER2 mobility
was unaffected by the CK1εTau mutation (Figure S4H). Further-
more, after bleaching nuclear fluorescence, full recovery of nu-
clear fluorescence did not occur within the experimental time
frame, confirming that the bulk (>90%) of PER2::VENUS was nu-
clear (Figure S4I). FRAP also was measured in SCN slices (Fig-
ure 4), yielding diffusion coefficients within cytoplasm or nucleus
of0.2 mm2s1. This is comparable to the slow diffusing compo-
nent revealed by FCS in fibroblasts (Figure 3E). The diffusion co-
efficient was calculated for both cytoplasm and nucleus, at CT12
and CT2. Intracompartment mobility was comparable for both
cytoplasm and nucleus at both time points (Figure 4D). PER2
mobility was not reduced in the nucleus, which may have been
expected for a transcriptional regulator. Translocation of PER2
into the nucleus is critical for the circadian TTFL [6, 7]. Thus,
T1/2 of FRAP was measured after photobleaching either the
whole nucleus or cytoplasm (Figures 4B and 4C; Movie S2) to
quantify between-compartment mobility. Importantly, this
showed that there is no compartmental or temporal restriction
over the mobility of PER2::VENUS (Figure 4E), in agreement
with the confocal time-lapse imaging data (i.e., movement be-
tween compartments was comparable in both directions).
CK1d/ε activity is an important regulator of the TTFL, where
CK1-mediated phosphorylation of PER proteins licenses them
for ubiquitination and proteasomal degradation. To test whether
CK1 modulates PER2 mobility, we treated SCN slices with
CK1 inhibitor PF670462, which slowed Per1-luc oscillations
to 28.6 ± 0.30 hr (n = 10, p < 0.01 versus pre-treatment).Current Biology 26, 1880–1886, July 25, 2016 1883
AB
D E
C
Figure 4. FRAP Reveals Role of CK1 in
Regulating PER2 Mobility in SCN Neurons
(A) A schematic diagram illustrating FRAP as fol-
lows: (1) select region and measure pre-bleach
fluorescence, (2) photobleach region, and (3)
monitor the recovery of fluorescence. The T1/2 is
calculated from the recovery curve.
(B) Snapshots from a FRAP experiment show
cytoplasmic photobleaching and fluorescence re-
covery in neurons in an SCN slice.
(C) Fluorescence recovery for a bleached cyto-
plasmic region (red) and unbleached nuclear
region (blue). The latter shows no change in fluo-
rescence over the time course.
(D) FRAP-derived diffusion coefficients (mean ±
SEM) within SCN nucleus and cytoplasm were
comparable at both peak and trough (CT2
and CT12) of the cycle (nCT2,cyto = 3 slices,
nCT12,cyto = 4, nCT2,nuc = 3, and nCT12,nuc = 4; two-
way ANOVA). Diffusion coefficients were esti-
mated from FRAP-derived T1/2 measures.
(E) FRAP-derived T1/2 (mean ± SEM) calculated
from total cytoplasm (Nuc to Cyto) and total
nucleus (Cyto to Nuc) FRAP of SCN neurons at
CT2 (left) and CT12 (right). Treatment with
PF670462 (1 mM) significantly decreased T1/2
times for PER2::VENUS (nCT2,WT,cyto = 4 slices,
nCT2,WT,nuc = 4, nCT2,PF,cyto = 5, nCT2,PF,nuc = 5,
nCT12,WT,cyto = 5, nCT12,WT,nuc = 6, nCT12,PF,cyto = 13,
and nCT12,PF,nuc = 12; two-way ANOVA with
Tukey’s comparison, ****p < 0.0001).
See also Figure S4 and Movie S2.Intracompartment mobility was unaffected by treatment with
PF670462 (Figures S4J and S4K); but, surprisingly, both at
CT2 and CT12 it significantly decreased the T1/2 of FRAP (Fig-
ure 4E; i.e., the rates of PER2::VENUS bi-directional transloca-
tion were accelerated). Furthermore, the magnitude of the in-
creases in T1/2 were consistent across time points (CT2/CT12)
and direction of movement (Figure S4K). Thus, decreasing CK1
activity increased PER2::VENUS translocation rates in an unbi-
ased manner. In conclusion, low CK1ε/d activity, which signifi-
cantly lengthened the period of the SCN TTFL, was associated
with accelerated nucleo-cytoplasmic shuttling of PER2::VENUS.
DISCUSSION
The PER2::VENUS mouse enables direct qualitative and quanti-
tative observations of the complex spatiotemporal behavior of
the PER2 protein, in a physiologically relevant setting. Our results
suggest a pivotal role for the dynamic balance of nuclear entry
and export for the determination of circadian period.
The PER2::VENUS allele was validated as clock competent, a
property shared with PER2::LUC [8, 12]. Luciferase reporter sys-
tems, however, are not suitable for measuring fast events, such
as nucleo-cytoplasmic shuttling of proteins. They produce a dim
signal necessitating a long integration time for detection, and
their inherent requirement for luciferin substrate can generate
luciferase-chemistry-dependent artifacts. Fluorescent proteins
do not suffer from these problems, but there are, of course,
some potential limitations, including altered stability of the
endogenous protein. The half-life of PER2::VENUS was similar
to PER2::LUC, suggesting that the Venus tag did not alter the1884 Current Biology 26, 1880–1886, July 25, 2016stability of the PER2 protein. PER2::LUC had a slightly shorter
half-life, but this is in line with published literature reporting
that luciferase-tagged reporters have a shorter half-life than their
endogenous counterparts [13]. The PER2::VENUS half-life may
be a more accurate estimate of PER2 stability, as it is a direct
measure of the protein, rather than using enzymatic luciferase
activity, which is an indirect measure. Prolonged fluorescence
imaging can cause both phototoxicity and photobleaching, but
for PER2::VENUS we found that it was possible to image SCN
slices and fibroblast cultures over at least 70 hr without loss
of fluorescence or circadian competence. Although there was
limited detection of cytoplasmic PER2::VENUS in fibroblasts,
photobleaching of the entire cytoplasm only reduced the nuclear
fluorescence by <2% at CT12; thus, it is unlikely to contribute
to the overall behavior of PER2 in this cell type. Overall, PER2::
VENUS is a useful and faithful reporter for monitoring PER2
dynamics over shorter and longer timescales.
In contrast to the Drosophila ortholog, dPer, which accumu-
lates in the cytoplasm prior to nuclear entry [3, 4], PER2 is not
subject to a circadian gate in SCN neurons and in fibroblasts.
This contrasting behavior may be explained by the proteins
having different hetero-dimerization partners (dTim and CRY,
respectively). Our data do not preclude nuclear gating of other
clock factors, but there is, so far, no evidence for this. For
example, snapshot immunostaining of PER1 in SCN highlights
nuclear expression and no cytoplasmic restriction [14]. Pro-
gression of the TTFL in the mammalian clock, therefore, is
not dependent on gated nuclear translocation; rather, it is
achieved by graded nuclear accumulation of the negative
regulators.
PER2::VENUS enabled us to quantify the number of PER2
molecules per cell and determine the dynamic changes in pro-
tein mobility. At CT12, PER2::VENUS was present at a concen-
tration of 15–20 nM in fibroblast nuclei, equating to >10,000
molecules. Interestingly, stochastic simulations of the mamma-
lian circadian clock predicted that stability within the virtual
TTFL required >4,000 molecules [15]. Thus, our real observa-
tions are of the same order of magnitude and can inform future
development of in silico models. The Per2Venusmouse also facil-
itates analysis of how the intracellular behavior of PER2 directs
the properties of the clock. Both FRAP and FCS revealed diffu-
sion coefficients principally in the range of 0.1 to 1.0 mm2s1.
This is broadly compatible with data from other dynamic
transcription factor proteins [16]. FCS also identified a more
mobile fraction in fibroblasts, with a coefficient of 10 mm2s1.
The obtained fast and slow diffusion constants (10 and
1 mm2s1), as well as free and bound fractions, are comparable
to estimates made by FCS for the in vivo binding of glucocorti-
coid receptor [17].
Numerous studies link CK1 to the regulation of PER2 function
and localization [18–20]. Both CK1εTau and hPer2S662G are mu-
tants that have a short circadian period, with altered phosphor-
ylation of PER2. The former exhibits rapid clearance of PER2
from the nucleus [10, 21] and the latter decreased nuclear reten-
tion [22–24]. These are two aspects of the same phenomenon.
Our data demonstrate that CK1 contributes to the translocation
of PER2 through the nuclear pores. Thus, CK1 is a critical regu-
lator of PER2 mobility and circadian period, although the contri-
bution of various types of mutation to short periods is not fully
resolved [25, 26].
In conclusion, PER2::VENUS operates as a functional circa-
dian protein, and it is sufficient to sustain timekeeping in the
absence of WT Per proteins. We believe that the fundamental
observations we have presented will support a significant reap-
praisal of themammalian clockmechanism and provide valuable
observational data on an endogenous clock protein that will
inform the development of enhanced quantitative models of
cellular circadian timekeeping.
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